Viva Biotech Holdings Statistics

Total Valuation

VBIZF has a market cap or net worth of 478.37 million. The enterprise value is 526.69 million.

Market Cap	478.37M
Enterprise Value	526.69M

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.11B
Shares Outstanding	n/a
Shares Change (YoY)	+41.39%
Shares Change (QoQ)	+67.85%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.01B

Valuation Ratios

The trailing PE ratio is 20.87 and the forward PE ratio is 9.43.

PE Ratio	20.87
Forward PE	9.43
PS Ratio	1.76
PB Ratio	0.91
P/TBV Ratio	2.73
P/FCF Ratio	19.05
P/OCF Ratio	9.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.76, with an EV/FCF ratio of 20.97.

EV / Earnings	22.98
EV / Sales	1.95
EV / EBITDA	8.76
EV / EBIT	16.92
EV / FCF	20.97

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.34.

Current Ratio	1.67
Quick Ratio	1.26
Debt / Equity	0.34
Debt / EBITDA	2.90
Debt / FCF	7.00
Interest Coverage	4.26

Financial Efficiency

Return on equity (ROE) is 5.92% and return on invested capital (ROIC) is 2.69%.

Return on Equity (ROE)	5.92%
Return on Assets (ROA)	1.98%
Return on Invested Capital (ROIC)	2.69%
Return on Capital Employed (ROCE)	3.88%
Revenue Per Employee	131,933
Profits Per Employee	11,110
Employee Count	2,063
Asset Turnover	0.27
Inventory Turnover	4.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +384.00% in the last 52 weeks. The beta is 1.27, so VBIZF's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+384.00%
50-Day Moving Average	0.16
200-Day Moving Average	0.65
Relative Strength Index (RSI)	57.71
Average Volume (20 Days)	4,682

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, VBIZF had revenue of 272.18 million and earned 22.92 million in profits. Earnings per share was 0.01.

Revenue	272.18M
Gross Profit	94.18M
Operating Income	31.47M
Pretax Income	40.51M
Net Income	22.92M
EBITDA	59.29M
EBIT	31.47M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 129.00 million in cash and 175.92 million in debt, giving a net cash position of -46.92 million.

Cash & Cash Equivalents	129.00M
Total Debt	175.92M
Net Cash	-46.92M
Net Cash Per Share	n/a
Equity (Book Value)	522.83M
Book Value Per Share	0.25
Working Capital	102.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 51.24 million and capital expenditures -26.12 million, giving a free cash flow of 25.11 million.

Operating Cash Flow	51.24M
Capital Expenditures	-26.12M
Free Cash Flow	25.11M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 34.60%, with operating and profit margins of 11.56% and 8.42%.

Gross Margin	34.60%
Operating Margin	11.56%
Pretax Margin	14.88%
Profit Margin	8.42%
EBITDA Margin	21.78%
EBIT Margin	11.56%
FCF Margin	9.23%

Dividends & Yields

VBIZF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.39%
Shareholder Yield	n/a
Earnings Yield	4.79%
FCF Yield	5.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VBIZF has an Altman Z-Score of 0.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	n/a